You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nivolumab

Showing 1 - 25 of 658
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

Not yet recruiting
  • Melanoma Stage IV
  • +3 more
  • nivolumab
  • (no location specified)
Dec 14, 2022

Melanoma Stage III, Melanoma Trial in Durham, Philadelphia (nivolumab, Ipilimumab)

Recruiting
  • Melanoma Stage III
  • Melanoma
  • Durham, North Carolina
  • +1 more
Mar 25, 2022

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Aug 19, 2022

Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

Not yet recruiting
  • Melanoma (Skin)
  • BMS-986213 (Relatlimab-Nivolumab FDC)
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Melanoma Trial in Pittsburgh (drug, biological, other)

Recruiting
  • Melanoma
  • Vidutolimod (CMP-001)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 25, 2022

Muscle-Invasive Bladder Carcinoma Trial in Milan (Nivolumab + Nab-paclitaxel, Nivolumab)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Nivolumab + Nab-paclitaxel
  • Nivolumab
  • Milan, MI, Italy
    Genitourinary Medical Oncology - IRCCS San Raffaele Hospital and
Mar 28, 2022

Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Hackensack, New Jersey
  • +1 more
Jun 2, 2022

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +2 more
Aug 15, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Gastric Cancer, Chemo Effect Trial (Nivolumab plus SOX, Nivolumab, Gastrectomy)

Not yet recruiting
  • Gastric Cancer
  • Chemotherapy Effect
  • Nivolumab plus SOX
  • +2 more
  • (no location specified)
Jan 7, 2022

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022

Esophageal Cancer Trial in Rotterdam (Nivolumab)

Not yet recruiting
  • Esophageal Cancer
  • Nivolumab
  • Rotterdam, Netherlands
    Erasmus MC
Aug 4, 2022

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Nivolumab
  • all trans retinoic acid
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Nivolumab
  • Moscow, Russian Federation
    National Research Center for Hematology
Dec 13, 2022

NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma Trial in Pittsburgh (Pixatimod, Nivolumab, Cyclophosphamide (low

Recruiting
  • NSCLC
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 28, 2022

Prostate Cancer Trial run by the NCI (PROSTVAC-V/F, Nivolumab)

Recruiting
  • Prostate Cancer
  • PROSTVAC-V/F
  • Nivolumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 12, 2022

Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • CapOx(Capecitabine+ Oxaliplatin)
  • +2 more
  • (no location specified)
Oct 18, 2022

Locally Advanced or Metastatic Melanoma Trial (CBL0137, Ipilimumab, Nivolumab)

Not yet recruiting
  • Locally Advanced or Metastatic Melanoma
  • (no location specified)
Aug 10, 2022

Refractory CNS Lymphoma, Relapsed Primary CNS Lymphoma, Primary CNS Lymphoma Trial in Hangzhou (Nivolumab)

Active, not recruiting
  • Refractory Central Nervous System Lymphoma
  • +2 more
  • Nivolumab
  • Hangzhou, Zhejiang, China
    Jianmin Zhang
Jul 3, 2022

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Nivolumab
  • +3 more
  • Tampa, Florida
  • +1 more
Jan 30, 2023

Pancreatic Cancer Trial in Herlev (drug, radiation, biological)

Not yet recruiting
  • Pancreatic Cancer
  • Nivolumab
  • +3 more
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Feb 8, 2023

Nasopharyngeal Carcinoma Trial in Singapore (Ipilimumab, Nivolumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
Jul 20, 2022

Solid Tumors Trial in Guangzhou, Hangzhou (Nivolumab)

Completed
  • Solid Tumors
  • Nivolumab
  • Guangzhou, Guangdong, China
  • +1 more
Mar 14, 2022

Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Feb 1, 2023

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +2 more
  • Nivolumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022